Liraglutide clinical trials: 262 trials
Page 5 of 6
- Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
NCT01473953 · Phase 1 · Completed
Posted results
- Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
NCT01856790 · Early phase 1 · Completed
Posted results
- Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
NCT03500484 · Early phase 1 · Terminated
Posted results
- Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
NCT01373450 · Phase 1 · Completed
Posted results
- Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
NCT02231658 · Phase 1 · Terminated
Linked paper with results
- Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
NCT01518166 · Phase 1 · Completed
Linked paper with results
- Effect of Liraglutide on Heart Frequency in Healthy Volunteers
NCT01516255 · Phase 1 · Completed
Linked paper with results
- A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
NCT02717858 · Phase 1 · Completed
Linked paper with results
- A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
NCT05294536 · Phase 1 · Completed
Linked paper with results
- A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
NCT00978393 · Phase 1 · Completed
Linked paper with results
- The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
NCT01536665 · Phase 1 · Completed
Linked paper with results
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
NCT02059564 · Phase 1 · Status unknown
Linked paper with results
- Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
NCT01511692 · Phase 1 · Completed
Linked paper with results
- To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo
NCT00761540 · Phase 1 · Completed
Linked paper with results
- Safety and Tolerability of Liraglutide in Healthy Male Volunteers
NCT01507272 · Phase 1 · Completed
Linked paper with results
- Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
NCT01507337 · Phase 1 · Completed
Linked paper with results
- Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
NCT01508806 · Phase 1 · Completed
Linked paper with results
- Human Bioequivalence Test of Liraglutide Injection
NCT05029076 · Phase 1 · Completed
Linked paper with results
- Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
NCT01507285 · Phase 1 · Completed
Linked paper with results
- A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
NCT02696148 · Phase 1 · Completed
Linked paper with results
- Safety and Tolerability of NN9068 in Healthy Male Volunteers
NCT00983021 · Phase 1 · Completed
Linked paper with results
- Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
NCT01515592 · Phase 1 · Completed
Linked paper with results
- Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
NCT00943501 · Phase 1 · Completed
Linked paper with results
- A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
NCT01789086 · Phase 1 · Completed
Linked paper with results
- A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
NCT00993304 · Phase 1 · Completed
Linked paper with results
- Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
NCT01511185 · Phase 1 · Completed
Linked paper with results
- Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes
NCT01517555 · Phase 1 · Completed
Linked paper with results
- Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes
NCT01507311 · Phase 1 · Completed
Linked paper with results
- Metabolism and Excretion of Liraglutide in Healthy Male Volunteers
NCT01517568 · Phase 1 · Completed
Linked paper with results
- Comparison of Type 2 Diabetes Pharmacotherapy Regimens
NCT05073692 · Phase not stated · Completed
Posted results
- A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
NCT03993132 · Phase not stated · Completed
Posted results
- Effects of Obesity Treatments on Food Preferences and Metabolism
NCT01724060 · Phase not stated · Completed
Posted results
- Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
NCT03010683 · Not applicable · Completed
Posted results
- Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
NCT02324842 · Not applicable · Completed
Posted results
- Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
NCT02777073 · Not applicable · Completed
Posted results
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
NCT01232946 · Not applicable · Completed
Posted results
- Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
NCT01226966 · Phase not stated · Completed
Linked paper with results
- Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
NCT03948347 · Not applicable · Status unknown
Linked paper with results
- Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
NCT01484262 · Phase not stated · Completed
Linked paper with results
- Comprehensive Clinical Evaluation Study of GLP-1RA
NCT06686134 · Phase not stated · Recruiting
Linked paper with results
- Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
NCT02930265 · Not applicable · Status unknown
Linked paper with results
- LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
NCT05313529 · Not applicable · Completed
Linked paper with results
- Liraglutide and Cardio-Metabolic Risk Markers
NCT01715428 · Phase not stated · Completed
Linked paper with results
- Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
NCT01288326 · Phase not stated · Completed
Linked paper with results
- Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
NCT07309094 · Phase not stated · Recruiting
Linked paper with results
- The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
NCT01472640 · Not applicable · Completed
Linked paper with results
- Effects of Glucagon Like Peptide-1 on No-reflow
NCT02507128 · Not applicable · Status unknown
Linked paper with results
- Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
NCT02001363 · Not applicable · Status unknown
Linked paper with results
- GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
NCT02577848 · Not applicable · Status unknown
Linked paper with results
- Tirzepatide vs Liraglutide in Bone
NCT07094568 · Phase not stated · Recruiting
Linked paper with results